ArticleBMC cancer2022

When to add anti-angiogenesis drugs to EGFR-mutated metastatic non-small cell lung cancer patients: a real-world study from Taiwan.

Chieh-Lung Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.